BEGIN:VCALENDAR
VERSION:2.0
PRODID:www.eu-parc.eu
BEGIN:VEVENT
UID:6a1d08d2b4ad6
DTSTART;VALUE=DATE:20250908
SEQUENCE:0
TRANSP:OPAQUE
DTEND;VALUE=DATE:20250909
SUMMARY:European Brain Barriers Meeting – Advances and Controversies in B
 rain Barriers Research 
CLASS:PUBLIC
DESCRIPTION:The 27th European Brain Barriers Meeting ↗ will take place in
  Bern\, Switzerland\, bringing together international experts in the field
  of brain barrier research. This annual event fosters dialogue on a wide r
 ange of topics extending beyond traditional signal transduction pathways\,
  covering developmental\, cellular\, structural\, and morphological aspect
 s of the blood-brain and blood-cerebrospinal fluid barriers.&nbsp\;The sci
 entific sessions include the physiological roles of brain barriers\, their
  involvement in cerebrospinal fluid dynamics\, and the therapeutic targeti
 ng of these critical interfaces\, making it a key platform for researchers
  working at the interface of basic and translational neuroscience.&nbsp\;W
 infried Neuhaus ↗ from the Austrian Institute of Technology GmbH ↗ (AI
 T\, Switzerland) will deliver a presentation titled “Development and App
 lications of Blood-Brain Barrier In Vitro Models for Neurotoxicity Assessm
 ent”\, showcasing innovative tools supporting chemical risk assessment i
 n the context of brain health.&nbsp\;We encourage scientists\, clinicians\
 , and regulatory professionals interested in neuropharmacology\, toxicolog
 y\, and blood-brain barrier research to attend the meeting in Bern. Don’
 t miss this opportunity to engage with cutting-edge science and contribute
  to shaping the future of brain barrier research.
X-ALT-DESC;FMTTYPE=text/html:<!doctype html><html><body><p>The <a href=\"ht
 tps://www.ebbmeeting.org/\"><strong>27<sup>th</sup> European Brain Barrier
 s Meeting</strong><span class=\"external-link-mark\"> ↗</span></a> will 
 take place in Bern\, Switzerland\, bringing together international experts
  in the field of brain barrier research. This annual event fosters dialogu
 e on a wide range of topics extending beyond traditional signal transducti
 on pathways\, covering developmental\, cellular\, structural\, and morphol
 ogical aspects of the blood-brain and blood-cerebrospinal fluid barriers.&
 nbsp\;</p><p>The scientific sessions include the physiological roles of br
 ain barriers\, their involvement in cerebrospinal fluid dynamics\, and the
  therapeutic targeting of these critical interfaces\, making it a key plat
 form for researchers working at the interface of basic and translational n
 euroscience.&nbsp\;</p><p><a href=\"https://www.linkedin.com/in/winfried-n
 euhaus-ba6ab9115/?originalSubdomain=at\">Winfried Neuhaus<span class=\"ext
 ernal-link-mark\"> ↗</span></a> from the <a href=\"https://www.ait.ac.at
 /en/\">Austrian Institute of Technology GmbH<span class=\"external-link-ma
 rk\"> ↗</span></a> (AIT\, Switzerland) will deliver a presentation title
 d <strong>“Development and Applications of Blood-Brain Barrier In Vitro 
 Models for Neurotoxicity Assessment”</strong>\, showcasing innovative to
 ols supporting chemical risk assessment in the context of brain health.&nb
 sp\;</p><p>We encourage scientists\, clinicians\, and regulatory professio
 nals interested in neuropharmacology\, toxicology\, and blood-brain barrie
 r research to attend the meeting in Bern. Don’t miss this opportunity to
  engage with cutting-edge science and contribute to shaping the future of 
 brain barrier research.</p></body></html>
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE
DTSTAMP:20260601T042138Z
END:VEVENT
BEGIN:VEVENT
UID:6a1d08d2b4b4c
DTSTART;VALUE=DATE:20250909
SEQUENCE:0
TRANSP:OPAQUE
DTEND;VALUE=DATE:20250910
SUMMARY:European Brain Barriers Meeting – Advances and Controversies in B
 rain Barriers Research 
CLASS:PUBLIC
DESCRIPTION:The 27th European Brain Barriers Meeting ↗ will take place in
  Bern\, Switzerland\, bringing together international experts in the field
  of brain barrier research. This annual event fosters dialogue on a wide r
 ange of topics extending beyond traditional signal transduction pathways\,
  covering developmental\, cellular\, structural\, and morphological aspect
 s of the blood-brain and blood-cerebrospinal fluid barriers.&nbsp\;The sci
 entific sessions include the physiological roles of brain barriers\, their
  involvement in cerebrospinal fluid dynamics\, and the therapeutic targeti
 ng of these critical interfaces\, making it a key platform for researchers
  working at the interface of basic and translational neuroscience.&nbsp\;W
 infried Neuhaus ↗ from the Austrian Institute of Technology GmbH ↗ (AI
 T\, Switzerland) will deliver a presentation titled “Development and App
 lications of Blood-Brain Barrier In Vitro Models for Neurotoxicity Assessm
 ent”\, showcasing innovative tools supporting chemical risk assessment i
 n the context of brain health.&nbsp\;We encourage scientists\, clinicians\
 , and regulatory professionals interested in neuropharmacology\, toxicolog
 y\, and blood-brain barrier research to attend the meeting in Bern. Don’
 t miss this opportunity to engage with cutting-edge science and contribute
  to shaping the future of brain barrier research.
X-ALT-DESC;FMTTYPE=text/html:<!doctype html><html><body><p>The <a href=\"ht
 tps://www.ebbmeeting.org/\"><strong>27<sup>th</sup> European Brain Barrier
 s Meeting</strong><span class=\"external-link-mark\"> ↗</span></a> will 
 take place in Bern\, Switzerland\, bringing together international experts
  in the field of brain barrier research. This annual event fosters dialogu
 e on a wide range of topics extending beyond traditional signal transducti
 on pathways\, covering developmental\, cellular\, structural\, and morphol
 ogical aspects of the blood-brain and blood-cerebrospinal fluid barriers.&
 nbsp\;</p><p>The scientific sessions include the physiological roles of br
 ain barriers\, their involvement in cerebrospinal fluid dynamics\, and the
  therapeutic targeting of these critical interfaces\, making it a key plat
 form for researchers working at the interface of basic and translational n
 euroscience.&nbsp\;</p><p><a href=\"https://www.linkedin.com/in/winfried-n
 euhaus-ba6ab9115/?originalSubdomain=at\">Winfried Neuhaus<span class=\"ext
 ernal-link-mark\"> ↗</span></a> from the <a href=\"https://www.ait.ac.at
 /en/\">Austrian Institute of Technology GmbH<span class=\"external-link-ma
 rk\"> ↗</span></a> (AIT\, Switzerland) will deliver a presentation title
 d <strong>“Development and Applications of Blood-Brain Barrier In Vitro 
 Models for Neurotoxicity Assessment”</strong>\, showcasing innovative to
 ols supporting chemical risk assessment in the context of brain health.&nb
 sp\;</p><p>We encourage scientists\, clinicians\, and regulatory professio
 nals interested in neuropharmacology\, toxicology\, and blood-brain barrie
 r research to attend the meeting in Bern. Don’t miss this opportunity to
  engage with cutting-edge science and contribute to shaping the future of 
 brain barrier research.</p></body></html>
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE
DTSTAMP:20260601T042138Z
END:VEVENT
BEGIN:VEVENT
UID:6a1d08d2b4b69
DTSTART;VALUE=DATE:20250910
SEQUENCE:0
TRANSP:OPAQUE
DTEND;VALUE=DATE:20250911
SUMMARY:European Brain Barriers Meeting – Advances and Controversies in B
 rain Barriers Research 
CLASS:PUBLIC
DESCRIPTION:The 27th European Brain Barriers Meeting ↗ will take place in
  Bern\, Switzerland\, bringing together international experts in the field
  of brain barrier research. This annual event fosters dialogue on a wide r
 ange of topics extending beyond traditional signal transduction pathways\,
  covering developmental\, cellular\, structural\, and morphological aspect
 s of the blood-brain and blood-cerebrospinal fluid barriers.&nbsp\;The sci
 entific sessions include the physiological roles of brain barriers\, their
  involvement in cerebrospinal fluid dynamics\, and the therapeutic targeti
 ng of these critical interfaces\, making it a key platform for researchers
  working at the interface of basic and translational neuroscience.&nbsp\;W
 infried Neuhaus ↗ from the Austrian Institute of Technology GmbH ↗ (AI
 T\, Switzerland) will deliver a presentation titled “Development and App
 lications of Blood-Brain Barrier In Vitro Models for Neurotoxicity Assessm
 ent”\, showcasing innovative tools supporting chemical risk assessment i
 n the context of brain health.&nbsp\;We encourage scientists\, clinicians\
 , and regulatory professionals interested in neuropharmacology\, toxicolog
 y\, and blood-brain barrier research to attend the meeting in Bern. Don’
 t miss this opportunity to engage with cutting-edge science and contribute
  to shaping the future of brain barrier research.
X-ALT-DESC;FMTTYPE=text/html:<!doctype html><html><body><p>The <a href=\"ht
 tps://www.ebbmeeting.org/\"><strong>27<sup>th</sup> European Brain Barrier
 s Meeting</strong><span class=\"external-link-mark\"> ↗</span></a> will 
 take place in Bern\, Switzerland\, bringing together international experts
  in the field of brain barrier research. This annual event fosters dialogu
 e on a wide range of topics extending beyond traditional signal transducti
 on pathways\, covering developmental\, cellular\, structural\, and morphol
 ogical aspects of the blood-brain and blood-cerebrospinal fluid barriers.&
 nbsp\;</p><p>The scientific sessions include the physiological roles of br
 ain barriers\, their involvement in cerebrospinal fluid dynamics\, and the
  therapeutic targeting of these critical interfaces\, making it a key plat
 form for researchers working at the interface of basic and translational n
 euroscience.&nbsp\;</p><p><a href=\"https://www.linkedin.com/in/winfried-n
 euhaus-ba6ab9115/?originalSubdomain=at\">Winfried Neuhaus<span class=\"ext
 ernal-link-mark\"> ↗</span></a> from the <a href=\"https://www.ait.ac.at
 /en/\">Austrian Institute of Technology GmbH<span class=\"external-link-ma
 rk\"> ↗</span></a> (AIT\, Switzerland) will deliver a presentation title
 d <strong>“Development and Applications of Blood-Brain Barrier In Vitro 
 Models for Neurotoxicity Assessment”</strong>\, showcasing innovative to
 ols supporting chemical risk assessment in the context of brain health.&nb
 sp\;</p><p>We encourage scientists\, clinicians\, and regulatory professio
 nals interested in neuropharmacology\, toxicology\, and blood-brain barrie
 r research to attend the meeting in Bern. Don’t miss this opportunity to
  engage with cutting-edge science and contribute to shaping the future of 
 brain barrier research.</p></body></html>
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE
DTSTAMP:20260601T042138Z
END:VEVENT
END:VCALENDAR